Sanary sur Mer, France

Claude Escarguel

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Diffusion Bacteriologie Du Var-d.b.v.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claude Escarguel. Retrieved from https://idiyas.com/inventor/claude-escarguel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claude Escarguel: Innovator in Diagnostic Solutions

Introduction

Claude Escarguel is a notable inventor based in Sanary-sur-Mer, France. He is currently associated with Inodiag, a company focused on innovative diagnostic solutions. Despite having no patents to his name, his contributions to the field of diagnostics are noteworthy.

Latest Patents

As of now, Claude Escarguel holds 1 patents. This indicates that his work may be more focused on research and development rather than patenting inventions.

Career Highlights

Throughout his career, Claude has been involved in various projects that aim to enhance diagnostic processes. His role at Inodiag has allowed him to collaborate with other professionals in the field, contributing to advancements in medical technology.

Collaborations

Unfortunately, details regarding specific collaborations are not available at this time.

Conclusion

Claude Escarguel is an innovative figure in the diagnostic industry, working diligently at Inodiag to improve healthcare solutions. His efforts, although not yet reflected in patents, demonstrate a commitment to advancing medical diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…